opioid addiction treatment Archives

FDA approves testing CBD for use in opioid addiction treatment

FDA approves testing CBD for use in opioid addiction treatment

Earlier this month, FDA gave the green light for human testing of CBD for opioid addiction treatment, a step further for the industry. Since part of addiction treatment is the reduction of craving, CBD will be tested in its ability to lessen the craving [...]

By Alex Villegas|January 28, 2022|Categories: CBD, Edible Oils, Food Technology|Tags: CBD oil, CBD-derived product manufacturers, COVID-19 tests, FDA, opioid addiction treatment, University of Chicago, University of Louisville|0 Comments

This website does not constitute an offer to sell, or a solicitation of an offer to buy or sell, any commodities interests, futures contracts, or options on futures contracts, and is intended for informational purposes only. McKeany-Flavell does not make any representations as to the accuracy or completeness of any data or information contained herein and information should not be relied upon as such. Some data and information presented in this report may have been obtained from outside sources. No guarantee of any kind is implied.

Investments or trading in commodities, futures, options on futures involves substantial risk of loss and may not be suitable for everyone. The valuation of futures and options may fluctuate and as a result, clients may lose more than their original investment. In no event should the content of this report be construed as an express or implied promise, guarantee, or implication by or from McKeany-Flavell that you will profit or that losses can or will be limited whatsoever. Past performance is not indicative of future results.